Disclosures for "Herpes Zoster Reports in Multiple Sclerosis Patients Treated With Disease Modifying Drugs – An Analysis of EudraVigilance Database"
-
Mr. Kulakowski has nothing to disclose.
-
Mr. Chrzanowski has received personal compensation for serving as an employee of AstraZeneca. Mr. Chrzanowski has a non-compensated relationship as a Board Member with Polish Society of Pharmacovigilance that is relevant to AAN interests or activities.
-
Dr. Niewada has received personal compensation for serving as an employee of HealthQuest Sp zoo. Dr. Niewada has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for pharmaceutical and medical devices companies. Dr. Niewada has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for HealthQuest. The institution of Dr. Niewada has received research support from MSD.
-
Prof. Mirowska-Guzel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Mirowska-Guzel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Mirowska-Guzel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo.